AgomAb Therapeutics NV (AGMB)
Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 20262 patents granted to the 2 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to AgomAb Therapeutics NV’s names, not what it holds today.
6 published
0 published
| Granted | Patent | Title | Field | Owner as printed |
|---|---|---|---|---|
| Sep 10, 2024 | 12,084,504 | Anti-MET antibodies and uses thereof | Pharmaceuticals | AGOMAB THERAPEUTICS |
| Dec 5, 2023 | 11,834,507 | Anti-MET agonist antibody for use in the treatment of colorectal cancer | Pharmaceuticals | AGOMAB THERAPEUTICS |
| Published | Application | Title | Field | Owner as printed |
|---|---|---|---|---|
| Jul 11, 2024 | 2024/0228632 | ANTI-MET ANTIBODIES AND USES THEREOF | Pharmaceuticals | AGOMAB THERAPEUTICS |
| Apr 25, 2024 | 2024/0132601 | ANTI-MET ANTIBODIES AND USES THEREOF | Pharmaceuticals | AGOMAB THERAPEUTICS |
| Nov 11, 2021 | 2021/0347901 | METHODS FOR PROMOTING PANCREATIC ISLET CELL GROWTH | Pharmaceuticals | AGOMAB THERAPEUTICS |
| Mar 25, 2021 | 2021/0087281 | HGF-MET AGONIST FOR USE IN THE TREATMENT OF CANCER AND COLORECTAL FIBROSIS | Pharmaceuticals | AGOMAB THERAPEUTICS · patent 11,834,507 granted from it |
| Jan 28, 2021 | 2021/0024639 | METHODS FOR PROMOTING PANCREATIC ISLET CELL GROWTH | Pharmaceuticals | AGOMAB THERAPEUTICS |
| Dec 31, 2020 | 2020/0407452 | METHODS FOR PROMOTING PANCREATIC ISLET CELL GROWTH | Pharmaceuticals | AGOMAB THERAPEUTICS |
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.